EQT Life Sciences Overview
EQT Life Sciences, formerly LSP, is a leading European life sciences investor with a 30-year history, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. With approximately €3.5 billion raised across 12 private funds and three investment strategies, the firm aims to back inventors with ideas that can significantly improve patients' lives.
Is EQT Life Sciences the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with EQT Life Sciences, along with a list of other relevant VCs, is available on Hopohopo.io.
EQT Life Sciences
Investment focus
Product type
- Software
- Hardware
- Software-enabled hardware
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- MedTech & Devices
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€10,000,000 - €60,000,000
Contact information
Director
Abhiram Rao
Partner
Anne Portwich
Managing Director
Daniela Begolo
Partner, Head of EQT Life Sciences
René R. Kuijten
How to approach funds like EQT Life Sciences
When approaching EQT Life Sciences, emphasize how your innovation addresses significant unmet medical needs and has the potential for substantial patient impact. Highlight your team's expertise and the scalability of your solution, aligning with their focus on transformative healthcare investments.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
